Sport boat manufacturer MasterCraft (NASDAQ:MCFT) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 20.6% year on year to $75.96 million. On the other hand, the company’s full-year revenue guidance of $275 million at the midpoint came in 3.7% below analysts’ estimates. Its non-GAAP profit of $0.30 per share was 70.5% above analysts’ consensus estimates.
Real estate firm JLL (NYSE:JLL) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 12.1% year on year to $5.75 billion. Its non-GAAP profit of $2.31 per share was 5.8% above analysts’ consensus estimates.
Workplace furnishings manufacturer HNI Corporation (NYSE:HNI) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 2% year on year to $599.8 million. Its non-GAAP profit of $0.44 per share was 29.4% above analysts’ consensus estimates.
Travel technology company Sabre (NASDAQ:SABR) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $776.6 million. Next quarter’s revenue guidance of $786.4 million underwhelmed, coming in 1.8% below analysts’ estimates. Its non-GAAP loss of $0 per share was in line with analysts’ consensus estimates.
Game engine maker Unity (NYSE:U) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 5.5% year on year to $435 million. On the other hand, next quarter’s revenue guidance of $420 million was less impressive, coming in 1.9% below analysts’ estimates. Its non-GAAP profit of $0.24 per share was significantly above analysts’ consensus estimates.
Holding company and industrial conglomerate Icahn (NYSE:IEP) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 19.1% year on year to $2.00 billion. Its GAAP loss of $0.79 per share was significantly below analysts’ consensus estimates.
Smart home company SmartRent (NYSE:SMRT) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 18.1% year on year to $41.34 million. Its non-GAAP loss of $0.21 per share was significantly below analysts’ consensus estimates.
Semiconductor manufacturer Vishay Intertechnology (NYSE:VSH) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 4.2% year on year to $715.2 million. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $760 million at the midpoint, or 0.8% above analysts’ estimates. Its non-GAAP loss of $0.03 per share was in line with analysts’ consensus estimates.
Global manufacturing solutions provider Flex (NASDAQ:FLEX) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 3.7% year on year to $6.40 billion. On the other hand, next quarter’s revenue guidance of $6.25 billion was less impressive, coming in 1.7% below analysts’ estimates. Its non-GAAP profit of $0.73 per share was 5.2% above analysts’ consensus estimates.
Natural food company Hain Celestial (NASDAQ:HAIN) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 11% year on year to $390.4 million. Its non-GAAP profit of $0.07 per share was 44.5% below analysts’ consensus estimates.
Insurance data analytics provider Verisk Analytics (NASDAQ:VRSK) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7% year on year to $753 million. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $3.06 billion at the midpoint. Its non-GAAP profit of $1.73 per share was 2.8% above analysts’ consensus estimates.
Lab services company Charles River Laboratories (NYSE:CRL) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 2.7% year on year to $984.2 million. Its non-GAAP profit of $2.34 per share was 12.8% above analysts’ consensus estimates.
Sales of Novo Nordisk’s flagship weight loss drug Wegovy surged 85% in the first quarter of the fiscal year 2025, while its diabetes treatment Ozempic posted an 18% increase.
Life sciences company Azenta (NASDAQ:AZTA) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 5.2% year on year to $143.4 million. Its non-GAAP profit of $0.07 per share was in line with analysts’ consensus estimates.
